Evaluation of the clinical value of pharmacists' modifications of prescription errors

被引:52
作者
Buurma, H
De Smet, PAGM
Leufkens, HGM
Egberts, ACG
机构
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmacoepidemiol & Pharmacotherapy, NL-3508 TB Utrecht, Netherlands
[2] SIR Inst Pharm Practice Res, Leiden, Netherlands
[3] Sci Inst Dutch Pharmacists WINAp, The Hague, Netherlands
[4] Radboud Univ Nijmegen Med Ctr, Dept Clin Pharm, Nijmegen, Netherlands
[5] TweeSteden Hosp, Hosp Pharm Midden Brabant, Tilburg, Netherlands
[6] St Elizabeth Hosp, Tilburg, Netherlands
关键词
community pharmacy services; drug-related problem; evaluation studies; intervention; pharmaceutical care; pharmacist; prescription; prescription error; prescription modification;
D O I
10.1111/j.1365-2125.2004.02181.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims Our objective was to examine the clinical value of pharmacists' interventions to correct prescription errors. Methods In this study, we reviewed a random sample of prescriptions that had been modified in pharmacies. These prescriptions were collected on one predetermined day between 25th February and 12th March 1999 from 141 Dutch community pharmacies. Each prescription modification was evaluated by a panel of reviewers, including representatives of five groups of health care professionals. After generally rating each modification as positive, negative, or neutral, the reviewers assessed its outcome (in terms of prevention of an adverse drug reaction [ADR], an improvement in effectiveness, both, or other), the probability and importance of improvements in effectiveness and/or the probability and seriousness of an ADR in the case of a nonintervention. Our analyses included 144 interventions from the first general assessment and a selection of 90 consistently rated 'positive' interventions (from all assessments). Results On average, one in 200 prescriptions (0.49%) was found to have been positively modified by Dutch community pharmacists. About half of these interventions (49.8%) were aimed at preventing ADRs; 29.2% were rated as a positive modification in the effectiveness of pharmacotherapy and 8.6% affected both effectiveness and ADR. Reviewers' ratings varied widely between different categories of drug-related problems (DRPs). The impact of individual interventions (n = 83) varied, and for 53% of these interventions it was estimated to be relatively high. Conclusions Pharmacists' interventions led to modification of prescriptions for an array of DRPs. Such interventions can contribute positively to the quality of pharmacotherapy. By extrapolating our data, we estimated a daily occurrence of approximately 2700 positive interventions in all Dutch pharmacies (1.6 per pharmacy per day). Reviewers rated the impact of interventions on a patient's health as significant in a substantial number of cases.
引用
收藏
页码:503 / 511
页数:9
相关论文
共 20 条
  • [1] Altman DG., 1995, PRACTICAL STAT MED R
  • [2] [Anonymous], 2000, Cochrane Database of Systematic Reviews, DOI [DOI 10.1002/14651858.CD000336, 10.1002/14651858.CD000336]
  • [3] Laxative prescribing in relation to opioid use and the influence of pharmacy-based intervention
    Bouvy, ML
    Buurma, H
    Egberts, TCG
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (02) : 107 - 110
  • [4] Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital
    Boyko, WL
    Yurkowski, PJ
    Ivey, MF
    Armitstead, JA
    Roberts, BL
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (14) : 1591 - 1595
  • [5] Nature, frequency and determinants of prescription modifications in Dutch community pharmacies
    Buurma, H
    de Smet, PAGM
    van den Hoff, OP
    Egberts, ACG
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (01) : 85 - 91
  • [6] Caleo SUE, 1996, INT J PHARM PRACT, V4, P221, DOI DOI 10.1111/j.2042-7174.1996.tb00872.x
  • [7] FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
  • [8] Identifying drug safety issues: from research to practice
    Gandhi, TK
    Seger, DL
    Bates, DW
    [J]. INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2000, 12 (01) : 69 - 76
  • [9] HANSTEN PD, 2002, DRUG INTERACTIONS AN
  • [10] Hawksworth GM, 1999, BRIT J CLIN PHARMACO, V47, P695